Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
BMJ (Clinical Research Ed.)|January 11, 2012
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT studyDerek J Rosario, J Athene Lane, Chris Metcalfe, et al.
Journal of Clinical Epidemiology|January 18, 2011
A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performanceJ Athene Lane, Julia Wade, Liz Down, et al.
BMJ Open|December 1, 2021
Best-BRA (Is subpectoral or prepectoral implant placement best in immediate breast reconstruction?): a protocol for a pilot randomised controlled trial of subpectoral versus prepectoral immediate implant-based breast reconstruction in women following mastectomyKirsty Roberts, Nicola Mills, Chris Metcalfe, et al.
Plos One|October 3, 2015
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on BiopsyRebecca Gilbert, Richard M Martin, David M Evans, et al.
BJU International|June 20, 2020
The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstructionSian M Noble, Aideen M Ahern, Jo Worthington, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|April 22, 2023
Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancerRachel Barker, Kalina Biernacka, Georgina Kingshott, et al.
Plos One|May 20, 2024
Rapid respiratory microbiological point-of-care-testing and antibiotic prescribing in primary care: Protocol for the RAPID-TEST randomised controlled trialSamantha Elizabeth Abbs, Lindsay Armstrong-Buisseret, Kathy Eastwood, et al.
Cancer Causes & Control : CCC|March 13, 2020
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigenSean Harrison, Kate Tilling, Emma L Turner, et al.
BJU International|July 15, 2016
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of lifeAthene Lane, Chris Metcalfe, Grace J Young, et al.
Pharmacoeconomics|October 6, 2022
Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP TrialEdna Keeney, Sabina Sanghera, Richard M Martin, et al.
Pageof 18